Menu
Search
Home > Courses > HBV & HIV: A Tale of Two Viruses and Many Drugs!

HBV & HIV: A Tale of Two Viruses and Many Drugs!

HBV & HIV: A Tale of Two Viruses and Many Drugs!
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 11/17/2009
Review Date: 11/17/2009
Presenter
  • Douglas T. Dieterich, MD
    Director for the Institute of Liver Medicine
    Icahn School of Medicine at Mount Sinai, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Explain the importance of diagnosing and evaluating HIV / HBV coinfection.
  2. Describe how to treat chronic hepatitis B in the setting of HIV coinfection.
  3. Discern renal toxicity issues in treating HIV & HBV.
  4. Explain the importance of screening for hepatocellular carcinoma (HCC) in HIV/HBV coinfected patients.
Presenter Bio
Douglas Dieterich, MD
Douglass Dieterich, MD is currently Director for the Institute of Liver Medicine at the Mount Sinai Health System and Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, New York, NY. Douglas T. Dieterich graduated from Yale University in New Haven, CT and received his Doctorate of Medicine from New York University of Medicine in NY. He completed his internship and residency in Internal Medicine at the Bellevue Hospital Center in New York, NY where he was also a fellow in the Division of Gastroenterology. Dr. Dieterich is an investigator for several ongoing studies evaluating the safety and efficacy of various antiviral treatment regimens for chronic hepatitis B & C, NASH and PSC.
PRN Learning Modules